International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases

mycopathologia

International journal of surgery (London, England)

canadian journal of kidney health and disease

[1] Transplant tourism and invasive fungal infection.

[2] Talaromyces marneffei Outside Endemic Areas in India: an Emerging Infection with Atypical Clinical Presentations and Review of Published Reports from India.

[3] Urolithiasis in renal transplant donors and recipients: An update.

[4] anticuerpos anticitomegalovirus y anti-virus de epstein barr pretrasplante renal en cuba

[5] emphysematous prostatitis in renal transplant

[6] severe diarrhoea due to cystoisospora belli in renal transplant patient on immunosuppressive drugs

[7] fatores de risco cardiovascular em pacientes pediátricos após um ano de transplante renal factores de riesgo cardiovascular en pacientes pediátricos después de un año de trasplante renal cardiovascular risk factors in pediatric patients after one year of renal transplant

[8] long-term change in central corneal thickness from a glaucoma perspective

[9] congenital combined eyelid imbrication and floppy eyelid syndrome: case report and review of literature

[10] renal graft survival according to banff 2013 classification in indication biopsies

[11] Acute Renal Transplant Failure Secondary to an Obstructing Ileal Conduit Adenocarcinoma: Case Report and Literature Review.

[12] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[13] Prevalence of resistance-associated substitutions to direct-acting antiviral agents in hemodialysis and renal transplant patients infected with hepatitis C virus [Erratum]

[14] Gastric Mucormycosis in a Renal Transplant Patient Treated with Isavuconazole Monotherapy

[15] Postinfectious Acute Glomerulonephritis in Renal Transplantation: An Emergent Aetiology of Renal Allograft Loss

[16] Deceased Donor Renal Transplantation Combined with Bilateral Nephrectomy in a Patient with Tuberous Sclerosis and Renal Failure

[17] [Relation between renal transplantation and work situation].

[18] Application of Machine-Learning Models to Predict Tacrolimus Stable Dose in Renal Transplant Recipients.

[19] Protocol-Based Nurse Coordinator Management of Ambulatory Tacrolimus Dosing in De Novo Renal Transplant Recipients - A Single Center Experience with a Large African American Population.

[20] A Prospective, Observational Study of Conversion From Immediate- to Prolonged-Release Tacrolimus in Renal Transplant Recipients in France: The OPALE Study.

[21] Comparative transcriptome analysis of peripheral blood mononuclear cells in renal transplant recipients in everolimus- and tacrolimus-based immunosuppressive therapy

[22] Combined approach with therapeutic drug monitoring and pharmacogenomics in renal transplant recipients

[23] The Bioethics and Utility of Selling Kidneys for Renal Transplantation

[24] Retrospective review of bone mineral metabolism management in end-stage renal disease patients wait-listed for renal transplant

[25] High Dimensional Renal Profiling: Towards a Better Understanding or Renal Transplant Immune Suppression.

[26] Is Early Conversion to mTOR Inhibitors Represent a Suitable Choice in Renal Transplant Recipients? A Systemic Review of Medium-term Outcomes

[27] Renal transplant results of the organ transplant center of meram medical school between 2003-2011

[28] Evaluating Emergency Department Admissions Among Renal Transplant Recipients: One Center Experience

[29] Update to the study protocol, including statistical analysis plan, for the multicentre, randomised controlled OuTSMART trial: a combined screening/treatment programme to prevent premature failure of renal transplants due to chronic rejection in patients with HLA antibodies.

[30] Tacrolimus predose concentrations do not predict the risk of acute rejection after renal transplantation: a pooled analysis from three randomized-controlled clinical trials(†).

[31] Computer-assisted cyclosporine dosing performs better than traditional dosing in renal transplant recipients: results of a pilot study.

[32] Determination of total, free and saliva mycophenolic acid with a LC-MS/MS method: application to pharmacokinetic study in healthy volunteers and renal transplant patients.

[33] Management of dyslipidemia in pediatric renal transplant recipients.

[34] Online Patient Portal Use and Time to Renal Transplantation in Patients on Hemodialysis.

[35] Urolithiasis in renal transplant donors and recipients: An update.

[36] Elucidating the molecular pathways and immune system transcriptome during ischemia-reperfusion injury in renal transplantation.

[37] Fertility Outcome After Renal Transplantation: A Single-Center Experience.

[38] In Vitro Fertilization After Renal Transplantation: A Single-Center Experience.

[39] Intrarenal Transplantation of Hypoxic Preconditioned Mesenchymal Stem Cells Improves Glomerulonephritis through Anti-Oxidation, Anti-ER Stress, Anti-Inflammation, Anti-Apoptosis, and Anti-Autophagy

[40] relation of magnesium level to cyclosporine and metabolic complications in renal transplant recipients

[41] technical modifications of ureteroneocystostomy in renal transplantation: an 18-year experience

[42] primary intracranial leiomyoma in renal transplant recipient

[43] adherencia al tratamiento inmunosupresor en el paciente adulto con trasplante renal immunosuppressive treatment compliance in adult renal transplant patient

[44] case of early-disseminated rhizopus microsporus var. microsporus mucormycosis in a renal transplant patient

[45] use of belatacept as alternative immunosuppression in three renal transplant patients with de novo drug-induced thrombotic microangiopathy

[46] massive pleural effusion in a renal transplant recipient on tacrolimus

[47] renal transplantation across abo barrier

[48] evaluation of psychiatric issues in renal transplant setting

[49] emphysematous prostatitis in renal transplant

[50] non-melanoma skin cancer in renal transplant recipients: a study in a brazilian reference center

[51] aspergillus pericarditis with tamponade in a renal transplant patient

[52] the mode of pretransplant dialysis does not affect postrenal transplant outcomes in african americans

[53] multiple brown tumours in a renal transplantation patient with hyperparathyroidism

[54] functional and histological improvement after everolimus rescue of chronic allograft dysfunction in renal transplant recipients

[55] postrenal transplant metastatic colonic neoplasm: posttransplant lymphoproliferative disorder or adenocarcinoma?

[56] anti-thymocyte globulin versus basiliximab induction in renal transplant recipients: long-term outcome

[57] donor-recipient size mismatch in paediatric renal transplantation

[58] bk virus nephropathy in a renal transplant patient: potential role of electron microscopy in diagnosis

[59] protocol biopsies for renal transplantation

[60] severe diarrhoea due to cystoisospora belli in renal transplant patient on immunosuppressive drugs

[61] cutaneous alternariosis in a renal transplant recipient: a case report and literature review

[62] active surveillance for adverse events among patients who underwent renal transplantation: a prospective observational study

[63] pseudoaneurysm at anastomotic site in a case of renal transplant: a rare postsurgical complication

[64] continous arterio-venous haemofilteration to regulate hyperkalaemia during renal transplantation -a case report.

[65] virus-associated hemophagocytic syndrome in renal transplant recipients: report of 2 cases from a single center

[66] transitional cell carcinoma of the kidney graft: an extremely uncommon presentation of tumor in renal transplant recipients

[67] facial rash in a renal transplant patient

[68] 7 case reports of renal transplantation in donors with multiple renal arteries (mra) and multiple anastomosis in recipient

[69] fatores de risco cardiovascular em pacientes pediátricos após um ano de transplante renal factores de riesgo cardiovascular en pacientes pediátricos después de un año de trasplante renal cardiovascular risk factors in pediatric patients after one year of renal transplant

[70] effect of apheresis for abo and hla desensitization on anti-measles antibody titers in renal transplantation

[71] the impact of pretransplant donor-specific antibodies on graft outcome in renal transplantation: a six-year follow-up study

[72] pneumonia and in-hospital mortality after renal transplantation

[73] surgical complications after renal transplantation in grafts with multiple arteries

[74] the effect of different glycaemic states on renal transplant outcomes

[75] calciphylaxis after renal transplant. three clinical cases report

[76] graft function and nutritional parameters in stable postrenal transplant patients

[77] unusual fungal infections in renal transplant recipients

[78] lymphocyte subpopulations during cytomegalovirus disease in renal transplant recipients

[79] podium session 7: renal transplantation & vascular surgery-i

[80] two cases of human t-lymphotropic virus type i-associated myelopathy/tropical spastic paraparesis caused by living-donor renal transplantation

[81] pediatric renal transplantation in a highly sensitised child—8 years on

[82] opportunistic infections following renal transplantation

[83] myceleal emphysematous cystitis complicating a renal transplant kidney

[84] reusing immunoadsorption column – making the abo incompatible renal transplant affordable

[85] the comparative survey of life quality in renal transplant recipients, peritoneal dialysis, and hemodialysis patients in kerman in the year 2013

[86] cytomegalovirus infection in renal transplant recipients diagnosed by nested-pcr

[87] anti-interleukin-2 receptor antibodies—basiliximab and daclizumab—for the prevention of acute rejection in renal transplantation

[88] paraoxonase 1 phenotype and mass in south asian versus caucasian renal transplant recipients

[89] can patients with schizophrenia undergo renal transplantation with success?

[90] risk-stratified cardiovascular screening including angiographic and procedural outcomes of percutaneous coronary interventions in renal transplant candidates

[91] initial experience with abo-incompatible live donor renal transplantation

[92] hyperuricemia, chronic renal disease and renal transplant (part ii)

[93] Renal transplant ultrasound: The nephrologist's perspective